Regeneron Pharmaceuticals, Inc. Announces Upcoming 2014 Investor Conference Presentations

TARRYTOWN, N.Y., Aug. 19, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

• Sanofi and Regeneron will host an IR Thematic Conference Call on Alirocumab at 8:30 a.m. Eastern Time on Tuesday, September 2, 2014
• Baird 2014 Healthcare Conference at 4:05 p.m. Eastern Time on Wednesday, September 3, 2014                 
• Citi's 9^th Annual Biotech Conference at 10:00 a.m. Eastern Time on Thursday, September 4, 2014
• Morgan Stanley Global Healthcare Conference at 8:45 a.m. Eastern Time on Monday, September 8, 2014

The sessions may be accessed through the Company's web site, www.regeneron.com,  on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron commercializes medicines for eye diseases, colorectal cancer, and a rare inflammatory condition, and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.

SOURCE Regeneron Pharmaceuticals, Inc.